A group of researchers led by theUniversity of California, San Francisco will spend $10 million over three years studying advanced prostate cancer, which is resistant to even the most promising treatments. Eric Small, M.D., deputy director of UCSF's cancer center, will lead the group, which the university characterizes as a "dream team."
No comments:
Post a Comment